A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

Abstract

The four-gene signature-derived risk score functions well in predicting the prognosis and treatment response in GBM and will be useful for guiding therapeutic strategies for GBM patients.